When patients switched to either fostemsavir or the combination of dolutegravir/lamivudine (DTG/3TC), suppression was maintained in most patients. Both dolutegravir ...
Newborns remain one of the most overlooked populations in the fight against HIV, with an estimated 120,000 new infections ...